期刊文献+

胃泌素释放肽前体在小细胞肺癌中的诊断价值 被引量:4

Diagnostic Value of Pro-gastrin-releasing Peptide in Small Cell Lung Carcinoma
下载PDF
导出
摘要 目的评价胃泌素释放肽前体(Pro GRP)对小细胞肺癌(SCLC)的诊断价值。方法选取2013年2月至2014年4月在蚌埠医学院第一附属医院住院治疗的70例SCLC患者(SCLC组)、40例非小细胞肺癌(NSCLC)患者(NSCLC组)及30例肺良性疾病(BDP)患者(BDP组)作为研究对象。采用化学发光免疫分析法和放射免疫分析法检测患者血清中Pro GRP和NSE的水平,探讨ProGRP诊断SCLC的价值。结果 SCLC组患者血清中Pro GRP[1088.05(437.51,2294.03)ng/L]和NSE[15.11(9.52,25.10)μg/L]的水平均显著高于NSCLC组[43.26(32.13,49.17)ng/L、[7.24(5.32,9.99)μg/L]和BPD组[38.46(30.81,43.72)ng/L、7.27(4.81,9.71)μg/L](P〈0.05)。以BPD为对照组,受试者工作特征(ROC)曲线确定的血清Pro GRP诊断SCLC的截断点为52.29 ng/L,ROC曲线下面积为0.982,95%CI 0.959~1.005;以NSCLC组为对照,血清Pro GRP和NSE的ROC曲线下面积分别为0.973和0.764,两者比较差异有统计学意义(Z=4.26,P〈0.05),获得Pro GRP诊断SCLC的截断点为86.96 ng/L。Pro GRP诊断SCLC的灵敏度、特异性、阳性预测值、阴性预测值及约登指数分别为88.6%、96.7%、98.4%、78.4%及0.852,均高于NSE的60.0%、90.0%、93.3%、49.1%、0.5。结论血清Pro GRP的水平对SCLC有较高的辅助诊断价值。 Objective To evaluate the diagnositic value of pro-gastrin-releasing peptide (ProGRP) in small cell lung carcinoma(SCLC). Methods From Feb. 2013 to Apr. 2014,70 SCLC patients (SCLC group) ,40 NSCLC patients( NSCLC group) and 30 benign pulmonary diseases (BPD group) in the First Affiliated Hospital of Bengbu Medical College were selected. The levels of serum ProGRP and NSE in the three groups were determined by chemiluminescent immunoassay and radioimmunoassay,respectively, and the diagnostic value of ProGRP in SCLC was investigaged. Results The serum ProGRP [ 1088.05 (437.51, 2294. 03) ng/L] and NSE [ 15.11 (9.52,25.10) μg/L] levels of SCLC group were significantly higher than those in NSCLC group [ 43.26 ( 32. 13,49. 17 ) ng/L, 7.24 ( 5.32,9.99 ) μg/L ] and BPD group [ 38.46 (30. 81,43.72 ) ng/L,7.27 (4. 81,9.71 ) μg/L ] ( P 〈 0. 05 ). BPD served as control group, the cut-off point of ProGRP was 52.29 ng/L, the area under the curve about receiver operator characteristic was O. 982,95% CI 0. 959-1. 005. NSCLC group served as the control, the area under the curve about receiver operator characteristic of ProGRP and NSE were 0. 973 and 0. 764, respectively. The area under curve of ProGRP was larger than NSE ( Z = 4. 670, P 〈 0.05 ), the cut-off point of ProGRP diagnosing SCLC was 86.96 ng/L. The sensitivity, specificity, positive predictive value, negative predictive value and Youden's index for SCLC were 88.6% ,96.7% ,98.4% ,78.4% and 0. 852,respectively,which were higher than the 60.0% ,90.0% ,93.3% ,49. 1% ,0. 5 for NSE. Conclusion ProGRP is quite helpful as auxiliary diagnosis in SCLC.
出处 《医学综述》 2015年第24期4552-4554,共3页 Medical Recapitulate
关键词 小细胞肺癌 胃泌素释放肽前体 神经元特异性烯醇化酶 Small cell lung carcinoma Pro-gastrin-releasing peptide Neuron-specific enolase
  • 相关文献

参考文献8

  • 1Jemal A,Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin,2008,58(2) :71-96. 被引量:1
  • 2殷蔚伯,余子豪,徐国镇,胡逸民主编..肿瘤放射治疗学 第4版[M].北京:中国协和医科大学出版社,2008:1374.
  • 3Detterbeck FC, Boffa D J, Tanoue LT. The new lung cancer staging system[J]. Chest,2009,136( 1 ) :260-271. 被引量:1
  • 4Moody TW,Pert CB, Gazdar AF, et al: High levels of intracellular bombesin characterize human small-cell lung carcinoma [ J ]. Sci- ence,1981,214(4526) :1246-1248. 被引量:1
  • 5Miyake Y, Kodama T, Yamaguchi K. Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma[ J]. Cancer Res, 1994,54 ( 8 ) :2136-2140. 被引量:1
  • 6Molina R, Aug6 JM, Bosch X, et al. Usefulness of serum tumor mark- ers, including progastrin-releasing peptide in patients with lung cancer: correlation with histology [ J ]. Tumour Biol, 2009,30 ( 3 ) : 121-129. 被引量:1
  • 7Molina R, Bosch X, Auge JM, et al. Utility of serum tumor mark- ers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown pri- mary site[ J]. Tumour Bio1,2012,33 ( 2 ) :463-474. 被引量:1
  • 8Lou E, Johnson M, Sima C, et al. Serum biomarkers for assessing his- tology and outcomes in patients with metastatic lung cancer [ J ]. Cancer Biomark.2014.14(4) :207-214. 被引量:1

同被引文献29

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部